Cargando…

Enrichment of the tumour immune microenvironment in patients with desmoplastic colorectal liver metastasis

BACKGROUND: Patients with resected colorectal liver metastasis (CRLM) who display only the desmoplastic histopathological growth pattern (dHGP) exhibit superior survival compared to patients with any non-desmoplastic growth (non-dHGP). The aim of this study was to compare the tumour microenvironment...

Descripción completa

Detalles Bibliográficos
Autores principales: Höppener, Diederik J., Nierop, Pieter M. H., Hof, Joost, Sideras, Kostandinos, Zhou, Guoying, Visser, Lydia, Gouw, Annette S. H., de Jong, Koert P., Sprengers, Dave, Kwekkeboom, Jaap, Vermeulen, Peter B., Grünhagen, Dirk J., Verhoef, Cornelis
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Nature Publishing Group UK 2020
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7374625/
https://www.ncbi.nlm.nih.gov/pubmed/32418992
http://dx.doi.org/10.1038/s41416-020-0881-z
_version_ 1783561733846073344
author Höppener, Diederik J.
Nierop, Pieter M. H.
Hof, Joost
Sideras, Kostandinos
Zhou, Guoying
Visser, Lydia
Gouw, Annette S. H.
de Jong, Koert P.
Sprengers, Dave
Kwekkeboom, Jaap
Vermeulen, Peter B.
Grünhagen, Dirk J.
Verhoef, Cornelis
author_facet Höppener, Diederik J.
Nierop, Pieter M. H.
Hof, Joost
Sideras, Kostandinos
Zhou, Guoying
Visser, Lydia
Gouw, Annette S. H.
de Jong, Koert P.
Sprengers, Dave
Kwekkeboom, Jaap
Vermeulen, Peter B.
Grünhagen, Dirk J.
Verhoef, Cornelis
author_sort Höppener, Diederik J.
collection PubMed
description BACKGROUND: Patients with resected colorectal liver metastasis (CRLM) who display only the desmoplastic histopathological growth pattern (dHGP) exhibit superior survival compared to patients with any non-desmoplastic growth (non-dHGP). The aim of this study was to compare the tumour microenvironment between dHGP and non-dHGP. METHODS: The tumour microenvironment was investigated in three cohorts of chemo-naive patients surgically treated for CRLM. In cohort A semi-quantitative immunohistochemistry was performed, in cohort B intratumoural and peritumoural T cells were counted using immunohistochemistry and digital image analysis, and in cohort C the relative proportions of individual T cell subsets were determined by flow cytometry. RESULTS: One hundred and seventeen, 34, and 79 patients were included in cohorts A, B, and C, with dHGP being observed in 27%, 29%, and 15% of patients, respectively. Cohorts A and B independently demonstrated peritumoural and intratumoural enrichment of cytotoxic CD8+ T cells in dHGP, as well as a higher CD8+/CD4+ ratio (cohort A). Flow cytometric analysis of fresh tumour tissues in cohort C confirmed these results; dHGP was associated with higher CD8+ and lower CD4+ T cell subsets, resulting in a higher CD8+/CD4+ ratio. CONCLUSION: The tumour microenvironment of patients with dHGP is characterised by an increased and distinctly cytotoxic immune infiltrate, providing a potential explanation for their superior survival.
format Online
Article
Text
id pubmed-7374625
institution National Center for Biotechnology Information
language English
publishDate 2020
publisher Nature Publishing Group UK
record_format MEDLINE/PubMed
spelling pubmed-73746252020-07-24 Enrichment of the tumour immune microenvironment in patients with desmoplastic colorectal liver metastasis Höppener, Diederik J. Nierop, Pieter M. H. Hof, Joost Sideras, Kostandinos Zhou, Guoying Visser, Lydia Gouw, Annette S. H. de Jong, Koert P. Sprengers, Dave Kwekkeboom, Jaap Vermeulen, Peter B. Grünhagen, Dirk J. Verhoef, Cornelis Br J Cancer Article BACKGROUND: Patients with resected colorectal liver metastasis (CRLM) who display only the desmoplastic histopathological growth pattern (dHGP) exhibit superior survival compared to patients with any non-desmoplastic growth (non-dHGP). The aim of this study was to compare the tumour microenvironment between dHGP and non-dHGP. METHODS: The tumour microenvironment was investigated in three cohorts of chemo-naive patients surgically treated for CRLM. In cohort A semi-quantitative immunohistochemistry was performed, in cohort B intratumoural and peritumoural T cells were counted using immunohistochemistry and digital image analysis, and in cohort C the relative proportions of individual T cell subsets were determined by flow cytometry. RESULTS: One hundred and seventeen, 34, and 79 patients were included in cohorts A, B, and C, with dHGP being observed in 27%, 29%, and 15% of patients, respectively. Cohorts A and B independently demonstrated peritumoural and intratumoural enrichment of cytotoxic CD8+ T cells in dHGP, as well as a higher CD8+/CD4+ ratio (cohort A). Flow cytometric analysis of fresh tumour tissues in cohort C confirmed these results; dHGP was associated with higher CD8+ and lower CD4+ T cell subsets, resulting in a higher CD8+/CD4+ ratio. CONCLUSION: The tumour microenvironment of patients with dHGP is characterised by an increased and distinctly cytotoxic immune infiltrate, providing a potential explanation for their superior survival. Nature Publishing Group UK 2020-05-18 2020-07-21 /pmc/articles/PMC7374625/ /pubmed/32418992 http://dx.doi.org/10.1038/s41416-020-0881-z Text en © The Author(s) 2020 https://creativecommons.org/licenses/by/4.0/Open Access This article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made. The images or other third party material in this article are included in the article’s Creative Commons license, unless indicated otherwise in a credit line to the material. If material is not included in the article’s Creative Commons license and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this license, visit http://creativecommons.org/licenses/by/4.0/ (https://creativecommons.org/licenses/by/4.0/) .
spellingShingle Article
Höppener, Diederik J.
Nierop, Pieter M. H.
Hof, Joost
Sideras, Kostandinos
Zhou, Guoying
Visser, Lydia
Gouw, Annette S. H.
de Jong, Koert P.
Sprengers, Dave
Kwekkeboom, Jaap
Vermeulen, Peter B.
Grünhagen, Dirk J.
Verhoef, Cornelis
Enrichment of the tumour immune microenvironment in patients with desmoplastic colorectal liver metastasis
title Enrichment of the tumour immune microenvironment in patients with desmoplastic colorectal liver metastasis
title_full Enrichment of the tumour immune microenvironment in patients with desmoplastic colorectal liver metastasis
title_fullStr Enrichment of the tumour immune microenvironment in patients with desmoplastic colorectal liver metastasis
title_full_unstemmed Enrichment of the tumour immune microenvironment in patients with desmoplastic colorectal liver metastasis
title_short Enrichment of the tumour immune microenvironment in patients with desmoplastic colorectal liver metastasis
title_sort enrichment of the tumour immune microenvironment in patients with desmoplastic colorectal liver metastasis
topic Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7374625/
https://www.ncbi.nlm.nih.gov/pubmed/32418992
http://dx.doi.org/10.1038/s41416-020-0881-z
work_keys_str_mv AT hoppenerdiederikj enrichmentofthetumourimmunemicroenvironmentinpatientswithdesmoplasticcolorectallivermetastasis
AT nieroppietermh enrichmentofthetumourimmunemicroenvironmentinpatientswithdesmoplasticcolorectallivermetastasis
AT hofjoost enrichmentofthetumourimmunemicroenvironmentinpatientswithdesmoplasticcolorectallivermetastasis
AT sideraskostandinos enrichmentofthetumourimmunemicroenvironmentinpatientswithdesmoplasticcolorectallivermetastasis
AT zhouguoying enrichmentofthetumourimmunemicroenvironmentinpatientswithdesmoplasticcolorectallivermetastasis
AT visserlydia enrichmentofthetumourimmunemicroenvironmentinpatientswithdesmoplasticcolorectallivermetastasis
AT gouwannettesh enrichmentofthetumourimmunemicroenvironmentinpatientswithdesmoplasticcolorectallivermetastasis
AT dejongkoertp enrichmentofthetumourimmunemicroenvironmentinpatientswithdesmoplasticcolorectallivermetastasis
AT sprengersdave enrichmentofthetumourimmunemicroenvironmentinpatientswithdesmoplasticcolorectallivermetastasis
AT kwekkeboomjaap enrichmentofthetumourimmunemicroenvironmentinpatientswithdesmoplasticcolorectallivermetastasis
AT vermeulenpeterb enrichmentofthetumourimmunemicroenvironmentinpatientswithdesmoplasticcolorectallivermetastasis
AT grunhagendirkj enrichmentofthetumourimmunemicroenvironmentinpatientswithdesmoplasticcolorectallivermetastasis
AT verhoefcornelis enrichmentofthetumourimmunemicroenvironmentinpatientswithdesmoplasticcolorectallivermetastasis